News & Trends - Pharmaceuticals
ARCS CEO reveals critical gaps in workforce and capability in pharma, medtech and biotech sectors
Pharma News: Several workforce and capability gaps across the pharma, medtech and biotech sectors have been identified from a recent Summit.
Dr Shanny Dyer, CEO of ARCS Australia joined Health Industry Hub in discussing key insights from the Workforce & Capacity Summit and recommendations on how the key gaps in workforce skills shortages, manufacturing capability and professional standards in regulatory and clinical trials can be addressed.
Shanny also shared ARCS Australia’s plans to engage with the government on these issues from an advocacy and partnership perspective to drive the necessary changes.
She concluded “Working together with a common purpose, right across the [pharma, medtech and biotech] sector can produce some really innovative thinking. Ideas that have enabled better access for patients, particularly around telehealth and teletrials, have been a major boost for our sector.
“We can keep that momentum going and keep working together to see how we can improve health outcomes for patients as a primary focus. Then all the things that we’re doing around building the workforce, getting appropriate infrastructure in place, getting the STEM students knowledgeable about the sector, will be a providing a really great outcome for Australia – both from a health perspective and an economic perspective.”
News & Trends - Pharmaceuticals
Heart Week: Uniting patient and cardiologist voices in shaping a new future for patient outcomes
Coinciding with the start of the Heart Week (9 – 12 May), Professor Gemma Figtree, Interventional Cardiologist and Immediate Past […]
MoreNews & Trends - MedTech & Diagnostics
‘It’s a marathon not a sprint’: Industry leaders chart next steps in medtech’s sustainability journey
Ahead of World Environment Day in June, Jane Crowe, Managing Director of Cardinal Health Australia and New Zealand and Pravin […]
MoreNews & Trends - Pharmaceuticals
Vaccination accounts for almost half of mortality decline in infants
Pharma News: Researchers have mapped the impact of vaccines to mark the 50-year anniversary of the Expanded Programme on Immunisation […]
MoreNews & Trends - Pharmaceuticals
AbbVie, Pfizer and Bayer therapies to be considered at upcoming PBAC intracycle meeting
Pharma News: Therapies from AbbVie, Pfizer and Bayer are due to be considered at the Pharmaceutical Benefits Advisory Committee (PBAC) […]
More